Column Group LLC - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.9%.

Quarter-by-quarter ownership
Column Group LLC ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$88,780,000
+44.5%
2,626,6310.0%12.57%
+113.5%
Q1 2021$61,437,000
-18.8%
2,626,6310.0%5.89%
-14.2%
Q4 2020$75,647,0002,626,6316.86%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q4 2020
NameSharesValueWeighting ↓
TRV GP, LLC 1,401,422$42,113,00092.36%
VR Adviser, LLC 4,016,873$120,707,00028.90%
Svennilson Peter 6,051,376$181,844,00015.21%
GREAT POINT PARTNERS LLC 3,480,000$104,574,0008.36%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,237,406$37,184,0005.22%
Ghost Tree Capital, LLC 650,000$19,533,0005.15%
Bain Capital Life Sciences Investors, LLC 1,400,000$42,070,0004.41%
Venrock Management V, LLC 1,557,276$46,796,0003.94%
Venrock Partners Management V, LLC 132,026$3,967,0003.94%
Avoro Capital Advisors LLC 4,000,000$120,200,0002.38%
View complete list of CONSTELLATION PHARMCETICLS I shareholders